Gentamicin Sulfate Prices

Gentamicin Sulfate Price Trend, Index and Forecast

Track the latest insights on gentamicin sulfate price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania

Gentamicin Sulfate Prices Outlook Q2 2025

• USA: US$ 163730/MT
• China: US$ 119000/MT
• Germany: US$ 171400/MT
• Netherlands: US$ 123500/MT
• Mexico: US$ 131150/MT

Gentamicin Sulfate Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, gentamicin sulfate prices in the USA reached 163730 USD/MT in June. Gentamicin sulfate prices in the U.S. stayed firm, supported by consistent demand in human and veterinary healthcare. Rising manufacturing expenses, stricter compliance requirements, and transportation bottlenecks constrained supply, contributing to upward pricing pressure. Regulatory oversight continued to elevate production costs, while stable consumption ensured demand strength. The combination of high input costs and logistical hurdles sustained a steady price environment throughout the quarter, with the U.S. market reflecting resilience despite persistent supply-side challenges.

During the second quarter of 2025, gentamicin sulfate prices in China reached 119000 USD/MT in June. Gentamicin sulfate prices in China showed persistent firmness, supported by strong export activity and robust domestic demand. Production costs rose due to higher raw material and energy expenses, while tighter regulatory enforcement added further supply-side constraints. Pharmaceutical and veterinary sectors sustained demand, ensuring consistent consumption. With supply chains facing intermittent disruptions, market sentiment stayed bullish. As a leading global supplier, China’s pricing trends influenced broader regional dynamics, keeping prices elevated and reflecting the balance between strong demand and restricted availability.

During the second quarter of 2025, the gentamicin sulfate prices in Germany reached 171400 USD/MT in June. Germany’s gentamicin sulfate market maintained a firm pricing outlook, supported by regulatory stringency and elevated production expenses. Energy price increases and higher operational costs added pressure on manufacturers, while strict compliance standards limited flexibility in supply. Demand from both pharmaceutical and veterinary sectors remained steady, further reinforcing pricing stability. Supply chain inefficiencies and cost burdens kept the market environment tight, ensuring prices stayed strong. Germany’s market reflected broader European trends, where stringent regulations and cost challenges shaped sustained firmness in gentamicin sulfate prices.

During the second quarter of 2025, the gentamicin sulfate prices in the Netherlands reached 123500 USD/MT in June. Gentamicin sulfate prices in the Netherlands likely followed broader European trends, with firm pricing driven by elevated production and compliance costs. Import dependency added pressure, as sourcing from other EU countries and global suppliers faced delays and rising logistics expenses. Healthcare and veterinary demand stayed consistent, but supply-side constraints limited market flexibility. Regulatory oversight and operational burdens reinforced the cost structure, resulting in steady pricing sentiment. The Netherlands thus mirrored regional conditions, where strong demand and constrained supply maintained a firm price environment.

During the second quarter of 2025, the gentamicin sulfate prices in Mexico reached 131150 USD/MT in June. Mexico’s gentamicin sulfate market showed steady pricing trends, largely influenced by U.S. supply dynamics and import dependence. Rising global production costs and transportation expenses pushed up overall supply chain burdens. Consistent demand from the healthcare and veterinary sectors ensured stable consumption levels, reinforcing market firmness. Regulatory oversight and limited domestic production capacity further contributed to reliance on imports. As a result, Mexican pricing aligned with international trends, remaining stable but under upward pressure due to elevated costs and cross-border sourcing challenges.

Gentamicin Sulfate Prices Outlook Q2 2023

• USA: US$ 145172/MT
• China: US$ 112400/MT
• Germany: US$ 158560/MT

The price of gentamicin sulfate in the USA for Q2 2023 reached 145172 USD/MT in June 2023.
The price of gentamicin sulfate in China for Q2 2023 reached 112400 USD/MT in June 2023.
The price of gentamicin sulfate in Germany for Q2 2023 reached 158560 USD/MT in June 2023.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the gentamicin sulfate prices.

Global Gentamicin Sulfate Price Trend

The report offers a holistic view of the global gentamicin sulfate pricing trends in the form of gentamicin sulfate price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of gentamicin sulfate, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed gentamicin sulfate demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Gentamicin Sulfate Price Trend

Q2 2025:

As per the gentamicin sulfate price index, European gentamicin sulfate prices remained firm, shaped by strong demand from the pharmaceutical and veterinary sectors. High production expenses, driven by energy costs and strict environmental regulations, placed sustained pressure on manufacturers. Supply was further tightened by dependency on imports from Asia, where rising export commitments reduced availability. Despite these challenges, healthcare demand remained resilient, ensuring stable consumption. Overall, the European market experienced elevated prices through the quarter, reflecting the combined effects of strong demand, regulatory pressure, and supply-side limitations.

Q2 2023:

European gentamicin sulfate prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed gentamicin sulfate price information for a comprehensive list of countries.

North America Gentamicin Sulfate Price Trend

Q2 2025:

North America maintained firm gentamicin sulfate pricing, largely supported by consistent demand across healthcare and veterinary sectors. Regulatory compliance standards and elevated manufacturing costs continued to play a critical role in shaping market trends. Supply chain inefficiencies and transportation challenges added to the pressure, preventing any major easing of prices. The market remained stable, reflecting resilience despite ongoing challenges. Overall, North America’s pricing environment was characterized by strong demand, high operating costs, and steady alignment with global upward momentum.

Q2 2023:

The analysis of gentamicin sulfate prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific gentamicin sulfate historical data within the United States and Canada can also be provided.

Middle East and Africa Gentamicin Sulfate Price Trend

Q2 2025:

The report explores the gentamicin sulfate trends and gentamicin sulfate price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices. 

In addition to region-wise data, information on gentamicin sulfate prices for countries can also be provided.

Asia Pacific Gentamicin Sulfate Price Trend

Q2 2025:

Gentamicin sulfate prices in the Asia Pacific strengthened, with China playing a key role in shaping regional market sentiment. Rising production costs, including raw material and energy expenses, supported the upward movement. Demand from both pharmaceutical manufacturers and veterinary applications remained strong, further tightening the supply-demand balance. Export commitments from leading producing nations also limited regional availability. Overall, APAC experienced a bullish pricing environment, driven by robust consumption and supply-side constraints, establishing the region as a crucial driver of global market dynamics.

Q2 2023:

The gentamicin sulfate pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This gentamicin sulfate price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Gentamicin Sulfate Price Trend

Q2 2025:

The gentamicin sulfate market in Latin America showed steady firmness, primarily due to its reliance on imports. Prices were influenced by supply trends in Asia and North America, where rising production and compliance costs shaped global availability. Logistics challenges and regulatory complexities in several countries further contributed to cautious supply conditions. Demand from the pharmaceutical and veterinary sectors remained stable, preventing major fluctuations. Overall, the regional market reflected moderate firmness, guided more by global supply patterns than local production.

Q2 2023:

The analysis of gentamicin sulfate prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Gentamicin Sulfate Price Trend, Market Analysis, and News

IMARC's latest publication, “Gentamicin Sulfate Pricing Report 2025: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” presents a detailed examination of the gentamicin sulfate market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of gentamicin sulfate at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed gentamicin sulfate prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting gentamicin sulfate pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Gentamicin Sulfate Industry Analysis

The global gentamicin sulfate market size reached US$ 540.56 Million in 2024. By 2033, IMARC Group expects the market to reach US$ 712.73 Million, at a projected CAGR of 2.96% during 2025-2033.

• One of the primary factors driving the market growth is the widespread product adoption in the treatment of complicated urinary tract infections (UTIs). Through its potent action against gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa, gentamicin sulfate is often administered when other antibiotics may not be effective. Its rapid bactericidal activity helps in quickly reducing bacterial load and alleviating the symptoms associated with severe UTIs, making it a critical option in urological therapy.
• Gentamicin sulfate is also utilized in the treatment of bone and joint infections, such as osteomyelitis and septic arthritis, which are often challenging to treat due to the difficulty of antibiotic penetration into bone tissue. This is contributing to the market expansion.
• Moreover, the global rise in healthcare expenditure is driving the demand for effective antibiotics like gentamicin sulfate. As countries invest more in healthcare infrastructure and services, the accessibility and utilization of antibiotics for treating severe infections are expected to increase. This rise in healthcare spending correlates with better diagnostic facilities and increased healthcare awareness, leading to a higher prescription rate of gentamicin sulfate for appropriate indications.
• Gentamicin sulfate has a broad spectrum of antibacterial activity, making it effective against a wide range of gram-negative and some gram-positive bacteria. Additionally, its rapid onset of action allows for a quick reduction in bacterial load, which is crucial in severe and life-threatening infections, thereby aiding in market expansion.
• Moreover, gentamicin sulfate is often used in combination with other antibiotics to enhance its efficacy and prevent bacterial resistance, which further provides an impetus to the market growth.
• Besides this, the veterinary medicine sector also represents a significant driver for the gentamicin sulfate market. The use of this antibiotic in treating bacterial infections in animals is widespread, particularly in livestock and poultry. The health of these animals directly impacts food safety and productivity, making effective antibiotics like gentamicin sulfate essential in the livestock sector, thus bolstering the market growth.

Gentamicin Sulfate News

The report covers the latest developments, updates, and trends impacting the global gentamicin sulfate market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in gentamicin sulfate production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the gentamicin sulfate price trend.

Latest developments in the gentamicin sulfate industry:

• In April 2024, Suanfarma addressed supply chain challenges by integrating hybrid fermentation and chemical synthesis in their production processes. This method enhances the efficiency and scalability of producing APIs, including gentamicin sulfate, ensuring a more reliable supply chain and consistent product quality​.
• In March 2024, the FDA approved two Sandoz biosimilars for two blockbuster Amgen bone drugs, Prolia and Xgeva. Prolia is marketed for osteoporosis, while Xgeva is used to prevent bone problems in multiple myeloma patients and solid tumors. Sandoz's biosimilar for osteoporosis will be called Jubbonti, while Wyost will be marketed for cancer.

Product Description

Gentamicin sulfate is an aminoglycoside antibiotic derived from Micromonospora purpurea, a type of actinobacteria. It is commonly used to treat a variety of bacterial infections. The compound is typically available in the form of a white to off-white powder that is soluble in water. As an aminoglycoside, gentamicin sulfate works by inhibiting bacterial protein synthesis, which ultimately leads to the death of susceptible bacteria.

It is widely used in both human and veterinary medicine due to its broad-spectrum antibacterial properties. In human medicine, it is often employed to treat severe infections such as septicemia, respiratory tract infections, urinary tract infections (UTIs), and infections of the bones and joints. Additionally, gentamicin sulfate is frequently used in combination with other antibiotics to enhance its effectiveness and broaden the scope of bacterial coverage.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of gentamicin sulfate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting gentamicin sulfate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The gentamicin sulfate price charts ensure our clients remain at the forefront of the industry.